Alpha Teknova Inc. (TKNO)
NASDAQ: TKNO
· Real-Time Price · USD
6.50
-0.11 (-1.66%)
At close: May 02, 2025, 3:59 PM
Alpha Teknova Revenue Breakdown
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Clinical Solutions Revenue | 1.96M | 1.56M | 1.72M | 879K | 597K | 3.65M | 1.61M | 772K | 919K | 2.94M | 3.81M | 2.44M | 1.69M | 1.59M |
| Clinical Solutions Revenue Growth | +25.50% | -8.91% | +95.45% | +47.24% | -83.66% | +127.04% | +108.42% | -16.00% | -68.77% | -22.80% | +56.29% | +44.32% | +6.09% | n/a |
| Lab Essentials Revenue | 7.16M | 7.64M | 7.27M | 6.69M | 7.27M | 7.58M | 7.26M | 6.93M | 9.47M | 8.39M | 6.97M | 6.74M | 7.2M | 6.46M |
| Lab Essentials Revenue Growth | -6.25% | +5.12% | +8.64% | -8.06% | -4.05% | +4.46% | +4.66% | -26.78% | +12.83% | +20.33% | +3.43% | -6.27% | +11.45% | n/a |
| Other Product Revenue | 451K | 411K | 306K | 300K | 298K | 293K | 255K | 185K | 303K | 354K | 354K | 432K | 434K | 227K |
| Other Product Revenue Growth | +9.73% | +34.31% | +2.00% | +0.67% | +1.71% | +14.90% | +37.84% | -38.94% | -14.41% | 0.00% | -18.06% | -0.46% | +91.19% | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2023 | Dec 31, 2022 |
|---|---|---|
| Non-Us Revenue | 1.68M | 1.32M |
| Non-Us Revenue Growth | +27.87% | n/a |
| United States Revenue | 35M | 40.1M |
| United States Revenue Growth | -12.72% | n/a |
Operating Expense Breakdown
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 6.61M | 6.94M | 7.75M | 8.43M | 8.55M | 8.12M | 9.69M | 10M | 8.9M | 9.66M | 8.89M | 8.07M | 6.49M | 4.74M | 4.87M | 4M | 2.29M | 2.14M | 2M |
| Selling, General, and Administrative Revenue Growth | -4.77% | -10.44% | -8.04% | -1.46% | +5.33% | -16.22% | -3.13% | +12.38% | -7.85% | +8.60% | +10.20% | +24.29% | +36.90% | -2.55% | +21.50% | +74.81% | +7.21% | +6.64% | n/a |
| Research and Development Revenue | 627K | 678K | 860K | 1.31M | 1.4M | 1.46M | 1.4M | 1.87M | 1.93M | 1.93M | 2.01M | 1.39M | 1.37M | 851K | 700K | 482K | 358K | 341K | 326K |
| Research and Development Revenue Growth | -7.52% | -21.16% | -34.40% | -6.16% | -4.58% | +4.95% | -25.40% | -2.86% | -0.21% | -4.17% | +44.82% | +1.31% | +61.22% | +21.57% | +45.23% | +34.64% | +4.99% | +4.60% | n/a |
| Sales and Marketing Revenue | 1.64M | 1.46M | 1.67M | 2.4M | 2.41M | 2.17M | 2.34M | 2.56M | 2.4M | 2.6M | 1.6M | 1.28M | 885K | 904K | 705K | 840K | 558K | 481K | 349K |
| Sales and Marketing Revenue Growth | +12.64% | -12.66% | -30.57% | -0.46% | +10.95% | -7.21% | -8.44% | +6.76% | -7.74% | +62.68% | +24.47% | +44.97% | -2.10% | +28.23% | -16.07% | +50.54% | +16.01% | +37.82% | n/a |